未分化リンパ腫キナーゼ
1 2 “Jeb signals through the Alk receptor tyrosine kinase to drive visceral muscle fusion”. Nature 425 (6957): 512–6. (October 2003). Bibcode: 2003Natur.425..512E. doi:10.1038/nature01950. PMID 14523447.
1 2 “Jelly belly protein activates the receptor tyrosine kinase Alk to specify visceral muscle pioneers”. Nature 425 (6957): 507–12. (October 2003). Bibcode: 2003Natur.425..507L. doi:10.1038/nature01916. PMID 14523446.
↑ “C. elegans anaplastic lymphoma kinase ortholog SCD-2 controls dauer formation by modulating TGF-beta signaling”. Current Biology 18 (15): 1101–9. (August 2008). doi:10.1016/j.cub.2008.06.060. PMC 3489285. PMID 18674914. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489285/.
(April 2002). doi:10.1074/jbc.M112354200. PMID 11809760.
↑ “Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin”. The Journal of Biological Chemistry 276 (20): 16772–9. (May 2001). doi:10.1074/jbc.M010660200. PMID 11278720.
↑ “Anaplastic thyroid cancers harbor novel oncogenic mutations of the ALK gene”. Cancer Research 71 (13): 4403–11. (July 2011). doi:10.1158/0008-5472.CAN-10-4041. PMC 3129369. PMID 21596819. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129369/.
↑ “Xalkori Approved for Lung Cancer”. FDA. 2022年9月3日閲覧。
↑ Gambacorti-Passerini CB, Dilda I, Giudici G, Perego A, Pavesi F, Guerra L, et al. Clinical activity of crizotinib in advanced, chemoresistant ALK+ lymphoma patients.